HIV-seroconversion among HIV-1 serodiscordant married couples in Tanzania: a cohort study. by Colombe, Soledad et al.
LSHTM Research Online
Colombe, Soledad; Beard, James; Mtenga, Baltazar; Lutonja, Peter; Mngara, Julius; de Dood, Clau-
dia J; van Dam, Govert J; Corstjens, Paul LAM; Kalluvya, Samuel; Urassa, Mark; +2 more... Todd,
Jim; Downs, Jennifer A; (2019) HIV-seroconversion among HIV-1 serodiscordant married couples
in Tanzania: a cohort study. BMC infectious diseases, 19 (1). p. 518. ISSN 1471-2334 DOI:
https://doi.org/10.1186/s12879-019-4151-8
Downloaded from: http://researchonline.lshtm.ac.uk/4654317/
DOI: https://doi.org/10.1186/s12879-019-4151-8
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
RESEARCH ARTICLE Open Access
HIV-seroconversion among HIV-1
serodiscordant married couples in
Tanzania: a cohort study
Soledad Colombe1* , James Beard2, Baltazar Mtenga3, Peter Lutonja3, Julius Mngara3, Claudia J. de Dood4,
Govert J. van Dam5, Paul L. A. M. Corstjens4, Samuel Kalluvya6, Mark Urassa3, Jim Todd2,3 and Jennifer A. Downs1,6
Abstract
Background: Heterosexual transmission is the main driver of the HIV epidemic in Tanzania. Only one estimate of the
incidence rate of intra-marital HIV seroconversion in Tanzania has been reported and was derived from data collected
between 1991 and 1995. Moreover, little is known about the specific risk factors for intra-marital seroconversion in
Tanzania. Improved evidence around factors that increase the risk of HIV transmission to a serodiscordant spouse is
needed to develop and improve evidence-based interventions. We sought to investigate the rate of intra-marital HIV
seroconversion among HIV sero-discordant couples in Tanzania as well as its associated risk factors.
Methods: We identified all HIV positive individuals in the TAZAMA HIV-serosurvey cohort and followed up their
serodiscordant spouse from 2006 to 2016. The rate of seroconversion was analyzed by survival analysis using non-
parametric regressions with exponential distribution.
Results: We found 105 serodiscordant couples, 14 of which had a seroconverting spouse. The overall HIV-1 incidence
rate among spouses of people with HIV-1 infection was 38.0 per 1000 person/years [22.5–64.1]. Notably, the HIV-1
incidence rate among HIV-1 seronegative male spouses was 6.7[0.9–47.5] per 1000 person/years, compared to 59.3
[34.4–102.1] per 1000 person/years among female spouses. Sex of the serodiscordant spouse was the only significant
variable, even after adjusting for other variables (Hazard rate = 8.86[1.16–67.70], p = 0.036).
Conclusions: Our study suggests that rates of HIV-1 seroconversion of sero-discordant partners are much higher
within marriage than in the general population in Tanzania. The major risk factor for HIV-1 seroconversion is sex of the
serodiscordant spouse, with female spouses being at very high risk of acquiring HIV infection. This suggests that future
programs that target serodiscordant couples could be a novel and effective means of preventing HIV-1 transmission in
Tanzania.
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Background
An estimated 790,000 new HIV infections occurred in
Southern and Eastern Africa in 2016. Of these, 55,000
happened in Tanzania, where the prevalence of HIV is
twice as high in women as in men [1]. Heterosexual
transmission is the main driver of the HIV epidemic in
Tanzania [2], with typical risk factors including presence
of sexually transmitted infections (STI), Schistosoma spp.
co-infection [3–5], low condom use, numerous sexual
partners, and lack of male circumcision [6].
In 2011, the Tanzania HIV/AIDS and Malaria indicator
survey showed that women and men who were married
were more likely to be HIV infected compared to men
and women that were never married [6]. Within mar-
riage, additional factors associated with increased risk of
HIV acquisition from a seropositive spouse include use
of hormonal contraception [7], concurrent sexual part-
nerships [8], alcohol use [8], age discordancy [9], genital
inflammation and discharge [10], non-antiretroviral
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(ART) use by the HIV-positive partner [11] and aware-
ness of the partner’s status [12].
In addition, women in either long-term relationships
or marriage are more at risk of acquiring HIV than men,
likely due to an array of cultural, social, economic, and
biological reasons [13]. In particular, male-to-female
HIV transmission occurs with higher frequency than
female-to-male transmission [14] and condoms are
rarely used in intimate relationships in Tanzania [15]. In-
timate partner violence and gender-based violence can
also prevent women from protecting themselves against
HIV [13] and women who experience intimate partner
violence are as much as 1.5 times more likely to acquire
HIV [13].
Only one estimate of the incidence rate of intra-
marital HIV seroconversion in Tanzania has been re-
ported and was derived from data collected between
1991 and 1995 [16]. Moreover, little is known about the
specific risk factors for intra-marital seroconversion in
Tanzania. Improved evidence around factors that in-
crease the risk of HIV seroconversion within serodiscor-
dant spouses is needed to develop and improve
evidence-based interventions.
We sought to investigate the rate of intra-marital HIV-
seroconversion within serodiscordant couples in Tanzania
as well as its associated risk factors. We hypothesized that
the rate of intra-marital HIV-seroconversion would be
more than twice as high as the rate of HIV-seroconversion
in the general population and that women would have
higher rates of acquiring HIV than men.
Methods
Identification of HIV-1 infected individuals
Our study was conducted within the ongoing TAZAMA
project, a community-based longitudinal open HIV-
testing cohort in Kisesa, northwest Tanzania, which doc-
uments detailed demographic, sexual, and behavioral
data and collects dried blood spots (DBS) approximately
every 3 years from a population of ~ 30,000 individuals.
Those wishing to know their HIV status may undergo
voluntary HIV testing and counseling on the same day
as collection of the DBS, and if tested positive, are re-
ferred to a treatment clinic. The HIV testing (sero-sur-
vey) is nested within a Demographic Surveillance System
(DSS) which visits every household in the catchment
area approximately every 9 months to document house-
hold members and relationships. Additional details have
been previously described [17]. Details collected from
both the DSS and sero-surveys included the start and
end dates of sexual relationships with both the spouse
with whom they lived and with external sexual partners
and the frequency of sexual intercourse.
For this project, we identified all individuals whose
DBS tested positive for HIV-1 or who were found to be
HIV-1 positive at an HIV testing clinic within the
TAZAMA cohort between 2006 and 2013. Throughout
the rest of the methods we will refer to these individuals
as “baseline individuals” for clarity and brevity.
Identification of serodiscordant spouse and relationship
time period
Through the DSS we identified all spouses of baseline
individuals and obtained their HIV-1 test results from
both the sero-surveys and from HIV tests at other
clinics. We excluded couples that were never serodiscor-
dant from the analysis, and couples for which the spouse
had HIV-1 seroconverted more than 6months after ei-
ther partner reported the end of the relationship. For
each couple, we determined the at-risk dates for HIV-1
seroconversion during which they reported being in a
sexual relationship with a partner who was HIV-1 posi-
tive. We collected demographic and sexual behavior data
from the first DSS or sero-survey following the start of
the serodiscordant relationship. Sexual behavior data in-
cluded the number of extra-marital partners, having sex
with sex workers, and traveling men.
We used data from all sero-surveys until the last sero-
survey with questions pertaining to the relationship time
period. Seroconverters were defined as individuals who
had been HIV-1 seronegative in one sero-survey and
who were found to be HIV-1 seropositive in a subse-
quent sero-survey. All DBS available until the date of
the spouse potential seroconversion were tested for
Schistosoma circulating anodic antigen for both the
baseline individual and his or her spouse.
Follow-up
The follow-up period started either from the start of the
relationship or from the first positive HIV result for the
baseline individual. The follow-up period ended either at
the spouse’s seroconversion date, or at the end of the re-
lationship, or at the last sero-survey for which a spouse
had an available HIV-1 test result and remained HIV-
seronegative. The seroconversion date was approximated
as the mid-point between the last negative DBS and the
first positive test, either at a sero-survey or at another
clinic.
Laboratory testing
Dried blood spots
DBS were collected by finger prick onto a Whatman
Protein Saver 903 card (GE Healthcare Bio-Sciences,
Pittsburgh, PA). DBS cards were dried out of direct sun-
light and sealed in a gas-impermeable zip bag with desic-
cant and humidity indicator. Cards were stored at the
National Institute for Medical Research (NIMR) labora-
tory in Mwanza at − 20 °C.
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HIV-1 testing
Diagnosis of HIV-1 infection was confirmed using a
screening and subsequent confirmatory test, as recom-
mended by national HIV guidelines, at each time point.
These were: Uniform II Category III Ab test followed by
Enzygnost test (sero-surveys 5 and 6), Uniform II Cat-
egory IV Ab+Ag test followed by Enzygnost test (sero-
survey 7), and Determine test followed by Unigold test
(sero-survey 8). Samples that were negative at the
screening test were reported as negative. Samples that
were positive at the screening test were tested with the
confirmatory test. If the confirmatory test was negative,
the final result was reported as negative. If the confirma-
tory test was positive, the final result was reported as
positive.
Schistosoma sp. testing
DBS were tested for schistosome for both HIV seronega-
tive and seropositive individuals by Circulating Anodic
Antigen (CAA) at Leiden University Medical Center by
eluting whole blood from banked DBS collected during
the sero-surveys and then concentrating the sample as
previously described [18]. The CAA test is a genus-
specific assay that detects a gut-associated antigen se-
creted into the host bloodstream by adult schistosome
worms. The test does not differentiate between the
Schistosoma mansoni and haematobium species present
in the Kisesa area of Tanzania. A lower limit threshold
of 2 pg CAA per mL of eluted blood was used for the
assay. Thirty-five individuals had stored serum samples
but no DBS samples available for testing and underwent
serum CAA testing at NIMR with a lower limit thresh-
old of 30 pg CAA per mL [19]. Samples scoring values
above the threshold were designated positive for Schisto-
soma infection, and a person with schistosome positivity
at any point in the time during the relationship was de-
fined as having the infection.
Statistical analysis
Analysis included all couples as described above. Binary
variables were described as proportions and continuous
variables were described using median and interquartile
range. We assessed differences in baseline characteristics
using Chi-square or Fisher’s exact test for proportions
and the nonparametric equality test for medians.
A survival analysis was conducted to investigate the
difference in HIV-1 seroconversion rates between spouse
of a baseline individual by sex. The event of interest was
defined as HIV-1 seroconversion. Data was censored at
the end of the relationship or for loss to follow-up, de-
fined as the last negative sero-survey at which the
spouse provided a DBS. The Kaplan-Meyer method was
used to compare time to seroconversion between the
HIV-serodiscordant spouses of baseline individuals for
males versus females. A parametric survival model with
exponential distribution, adjusted for all significantly dif-
ferent baseline factors as well as biologically sound vari-
ables, was used to assess endpoint incidence difference
by schistosome infection status. Time-dependent vari-
ables characterized at each sero-survey (such as number
of extra-marital sex partners, frequency of sex, etc) were
defined as representative of the time period following
the sero-survey and are called “survey-dependent vari-
ables” for the rest of the manuscript.
Variables that were associated with failure at 10% sig-
nificance were individually included into the model and
model goodness-of-fit assessed through step-wise ana-
lysis. Based on the results of the analysis, a second ana-
lysis was performed after stratifying by sex of the
serodiscordant spouse. All analyses were performed in
STATA 14.1 (College Station, TX, USA). All results were
expressed with 95% confidence intervals (CIs) and statis-
tical significance was set at P < 0.05 (two-tailed).
We conducted a sensitivity analysis in which survey-
dependent variables were defined as representative of
the time period preceding the sero-survey results. Finally
we conducted a second sensitivity analysis in which we
excluded all couples for which the baseline individual
was on ART.
Ethics, consent and permissions
Ethical approval for retrospective and prospective ana-
lysis of these data was obtained from Bugando Medical
Centre in Mwanza (BREC/001/04/2011), the National
Institute for Medical Research in Dar es Salaam (NIMR/
HQ/R.8a/Vol.IX/2446), and Weill Cornell Medicine in
New York (1108011883). Study participants provided
written informed consent during enrollment into the co-
hort study as per the approved procedures of the
TAZAMA project, which included consent for future
testing of DBS samples [17].
Results
We identified 1439 baseline individuals who were found
to be HIV-1 seropositive at a sero-survey between 2006
and 2013. Of these 554 had at least one spouse regis-
tered in the DSS after the time of the baseline individ-
ual’s first positive test. Among the 554, 289 had at least
one spouse who had HIV-1 test results and 105/289
were serodiscordant couples between 2006 and 2016
who met criteria for inclusion in this analysis. From
these serodiscordant couples, this yielded 368.8 years of
total analysis time at risk and under observation.
63.8% (67/105) of couples had a male baseline individ-
ual and a female serodiscordant spouse. An overwhelm-
ing proportion of baseline individuals and spouses were
of Sukuma ethnicity (97.1% (102/105) and 92.4% (97/
105), respectively), Christian (83.8% (88/105) and 92.4%
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(87/105), respectively), and reported having only one
spouse (87.6% (92/105) and 90.5% (95/105), respectively)
. 52.2% (48/92) of the baseline individuals were schisto-
some positive. 54.5% (55/101) of the serodiscordant
spouses were schistosome positive. All couples were het-
erosexual. The demographics of the population are pre-
sented in Table 1 as a comparison between the 14
people who HIV-seroconverted during follow-up and
the 91 people who did not. Serosurvey-dependent vari-
ables are presented in Table 2.
14/105 (13.3%) partners HIV-1 seroconverted, and 13 of
these were women. The overall HIV-1 incidence rate
among spouses of people with HIV-1 infection was 38.0
per 1000 person/years [22.5–64.1]. Notably, the HIV-1 in-
cidence rate among HIV-1 seronegative male spouse was
6.7[0.9–47.5] per 1000 person/years, compared to 59.3
[34.4–102.1] per 1000 person/years among female spouse.
After univariable analysis, sex of the serodiscordant
partner was the only variable that was significantly asso-
ciated with HIV-1 seroconversion. HIV-1 uninfected
female spouses of HIV-1 infected male baseline individ-
uals were found to have higher incidence rates of sero-
conversion than HIV-1 uninfected male spouses of HIV-
1 infected female baseline individuals (Hazard ratio
(HR) = 8.77, p = 0.036). None of the spouses of baseline
individuals on ART or with formal education serocon-
verted. None of the serodiscordant spouses in a polyg-
amous marriage or with reported extra-marital partners
acquired HIV. Results of the univariable analyses are
presented in Table 2.
After stepwise multivariable analysis, sex of the sero-
discordant partner was the only variable that yielded a
best of fit model. Female spouses thus had a rate of sero-
conversion 8.77[1.15–67.04] times higher than male
spouses (p = 0.036). The Kaplan-Meyer survival curves
by spouse sex are presented in Fig. 1.
After running the sensitivity analyses, when survey-
dependent variables were defined as representative of
the time period preceding the sero-survey results, the
hazard ratio for female spouses was 8.86[1.16–67.70],
p = 0.036. When excluding all couples on ART from the
analysis, the hazard ratio for female spouses was still
8.89[1.16–67.92], p = 0.035. Finally, when stratifying by
sex, none of the variables were significantly associated
with seroconversion.
Discussion
In this in-depth study of a community of approximately
30,000 individuals, the intra-marriage HIV-incidence in
our study population was overall 19 times the general
national HIV-incidence [1]. This effect was largely due
to women being highly susceptible to incident HIV in-
fection, yielding an incidence of 60 seroconversions per
1000 person-years in women and only 7 per 1000
person-years in men. This is a greater than eight-fold in-
crease in HIV acquisition in women as compared to
men, and suggests that intra-marriage seroconversion in
serodiscordant couples deserves more attention in
Tanzania, and that disproportionate transmission from
men to women, particularly in the absence of female-
Table 1 Characteristics of the spouse, baseline individual and couple by spouse seroconversion status
Variable Non-seroconverters
N = 91
Seroconverters
N = 14
p-value
Variables concerning the baseline individual
Sex (Female) 40.7% (37/91) 7.1% (1/14) 0.016
Education (Received at least 1 year of formal schooling) 24.4% (22/90) 0.0% (0/14) 0.037
ART intake 12.1% (11/91) 0% (0/14) 0.353
Marital status (Polygamy) 13.2% (12/91) 7.1% (1/14) 1
Age in years at the start of the time period of interest 39[33–45] 44[37–53] 0.125
Schistosome CAA positivity 51.3% (41/80) 58.3% (7/12) 0.647
Variables concerning the serodiscordant spouse
Sex (Female) 59.3% (54/91) 92.9% (13/14) 0.016
Education (Received at least 1 year of formal schooling) 42.9% (39/91) 21.4% (3/14) 0.037
Marital status (Polygamy) 12.1% (11/91) 0% (0/14) 0.353
Age in years at the start of the time period of interest 37[31–46] 35.5[32–46] 0.828
Male and circumcised 46.4% (13/28) – –
Schistosome CAA positivity 54.0% (47/87) 57.1% (8/14) 0.828
Variables concerning the couple
Age difference between the baseline individual and his/her spouse -3[−9;4] −5[−8;-4] 0.246
Length of the time period of interest (in days) 1029 [691–1882] 1093.5[571–1150.5] 0.228
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controlled HIV-prevention measures, may continue to
push the HIV epidemic towards female predominance.
Only one other estimate of the intra-marriage HIV-
incidence in Tanzania has been published, reporting a
rate of HIV seroconversion among serodiscordant
couples of 75(28–163) per 1000 person-years between
1991 and 1995, with the rate of seroconversion for
women only being twice as high as the rate of sero-
conversion for men [16]. The difference between the
prior and current findings reflects the large decrease
in HIV incidence in Tanzania over the past 30 years
as well as changes in drivers of the epidemic, such as
Table 2 Results of the univariable analysis for factors associated with HIV-1 seroconversion
Variable Person-time
(in years)
Number of
events
Hazard ratio
[95%CI]
p-value
Variables concerning the baseline individual
Sex Male 221.50 13 0.11[0.015–0.87] 0.036
Female 149.43 1
Education Never attended school 294.91 14 0[0]a 0.992
Ever attended school 71.01 0
ART intake No 318.72 14 0[0]a 0.992
Yes 50.06 0
Ln(CAA)d – – – 1.18[0.93–1.49] 0.177
STI symptoms No 291.31 11 1.03[0.29–3.68] 0.969
Yes 77.46 3
Schistosome CAA positivity Negative 167.80 5 1.35[0.43–4.24] 0.611
Positive 172.27 7
Variables concerning the serodiscordant spouse
Sex Male 149.43 1 8.77[1.15–67.04] 0.036
Female 221.50 13
Education Never attended school 234.99 11 0.48[0.13–1.72] 0.258
Ever attended school 135.94 3
Other risks for HIVbd No 297.77 14 0[0]a 0.994
Yes 71.00 0
Risky sex behaviorc,d No 66.43 4 0[0]a 0.994
Yes 19.15 0
Ln(CAA) d – – – 1.11[0.85–1.44] 0.453
Number of extramarital partnersd None 303.95 14 0[0]a 0.994
One or more 66.97 0
STI Symptomsd No 285.8 12 0.57[0.13–2.57] 0.468
Yes 82.94 2
Schistosome CAA positivity Negative 152.33 6 1.03[0.36–2.98] 0.953
Positive 196.75 8
Variables concerning the couple
Age difference between the baseline
individual and his/her spouse in years
– – – 1.00[0.9991–1.001] 0.734
Sex frequencyd Less than once a month 37.22 1
Between once a month and
once a week
134.64 6 1.66[0.20–13.78] 0.639
More than once a week 166.50 5 1.12[0.13–9.57] 0.919
aNo convergence of the model due to presence of zeros. No conclusion on the association between the variable and seroconversion can be made due to short
person-time available. ART was still included in the final model stepwise analysis
bOther risks for HIV include incisions and transfusions
cRisky sex behaviors include having sex with women at bars or with traveling men
dSurvey-dependent variables
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changes in sexual behavior and women’s susceptibility.
In other countries in Sub-Saharan Africa, reported
HIV incidence in HIV-serodiscordant couples concord
with our results, although varies widely (from 20 to
118 per 1000 person-years) [20–22]. Of note, these
studies reported rates in serodiscordant negative fe-
males less than twice as high as rates in serodiscor-
dant negative males [20].
Although uptake of ART among HIV-serodiscordant
couples has been recommended where feasible [23], it
does not remove the need for behavioral interventions
to reduce HIV acquisition from outside partners [12].
Serodiscordance within a couple may lead to in-
creased outside-partnership sex and increased risk of
outside transmission [12]. Tanzania has not focused
its efforts on serodiscordant couples yet and these re-
sults suggest that future programs that target serodis-
cordant couples may be an effective way to prevent
HIV-1 transmission in Tanzania. Couples’ voluntary
HIV counseling and testing significantly reduces HIV
transmission in discordant couples and has been
shown to increase a couple’s knowledge about HIV
serodiscordance and prevention behaviors [21]. In the
light of the shift to test-and-treat strategies, couples’
targeted-strategies for increasing uptake of ART could
be a key tool to achieve the goal of eliminating HIV
transmission, and this should include specific HIV
prevention messages to the HIV negative partner.
Surprisingly, the usual risk factors for HIV-1 sero-
conversion within marriage, such as sex frequency,
count of extra-marital sex partners and age difference
with the spouse, were not significant within our co-
hort [24]. It is possible that this was due to the
higher age of our study participants than has been
observed in most other serodiscordant couple studies
[4, 16]. In these older adults, traditional HIV risk
factors may be less important. Our results are con-
sistent with the well-described finding that, per sex
act, women are indeed more at risk of HIV-1 infec-
tion than men [25], likely due to a larger surface area
of the vagina and the ability of the virus to pass eas-
ily through the cells of the vaginal lining. Too few
partners were on ART to assess the role of ART on
seroconversion in our study, although the finding that
no partners of baseline individuals on ART serocon-
verted is consistent with other studies that showed
lower incidence of HIV when HIV positive partner
was on ART.
Our study supports findings of a large independent
serodiscordant couples’ study in Zambia. Our estimate
of the role of schistosome infection in the transmit-
ting partner on HIV-1 incidence (HR = 1.35, p = 0.6) is
of similar magnitude of that found in the much larger
Zambia study [4] (adjusted HR between 1.4 and 1.8,
p < 0.005) and shows a directional trend towards an
increased transmission of HIV-1 from baseline indi-
viduals infected with Schistosoma spp.. Schistosome
infection could lead to genital inflammation and ex-
posure to blood or higher genital tract HIV-1 RNA
viral loads [26, 27]. Schistosoma spp. leads to higher
HIV-1 RNA plasma viral load as well [5], which is
highly predictive of transmission to sexual partners
[28]. Even though our project was located in a com-
munity cohort of 30,000 people, our sample size of
discordant couples provided only enough power (80%)
to detect significance for a hazard ratio of 3.7 or
above, far higher than the hazard ratio estimates ob-
tained by this or the Zambia study. Our study simi-
larly may have lacked power to document an effect of
schistosome status on HIV acquisition in the receiving
partner, which has previously been documented in
other studies [5, 29].
Our results are to be interpreted in light of some
limitations. We were unable to test for viral loads, or
additional immunologic markers that might provide
insight into the reasons for our observations, due to
insufficient quantity of blood in DBS. We were also
unable to perform phylogenetic analyses that would
have permitted determination of whether the HIV-
seroconverting partner had been infected from a part-
ner outside of the marriage. Partners might also
under or overestimate the number of extra-marital
sexual partners based on their gender [30]. Further
studies with larger numbers of seroconverters should
be undertaken, which should include better assess-
ment of loss to follow up among the HIV negative
marital partners of PLHIV. Despite those limitations,
our finding that all sensitivity analyses gave the same
results strengthens confidence in the quality and ac-
curacy of our analysis.
Fig. 1 Kaplan-Meier survival estimates for seroconversion by sex of
the spouse. The curve represents the risk of seroconverting over
time by sex of the serodiscordant spouse
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Conclusions
In conclusion, our study suggests that rates of HIV-1
seroconversion are much higher within marriage than in
the general population in Tanzania. The major risk fac-
tor for HIV-1 seroconversion is sex of the serodiscordant
spouse, with female spouses being at very high risk of
HIV-seroconverting.
This suggests that future programs that target serodis-
cordant couples, regardless of source of infection, could
be a novel and effective means of preventing HIV-1
transmission in Tanzania. In addition, future studies
should explore the source of HIV acquisition in order to
focus HIV prevention efforts on specific risk groups.
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